Drug Firms Face Billions in Losses in '11 as Patents End

March 9, 2011

Related

Celltrion to buy US biologics manufacturing plant as part of tariff response strategy

Celltrion to buy US biologics manufacturing plant as part of tariff response strategy

‘Cobots’ drive pharma’s shift toward scalable cell therapies

‘Cobots’ drive pharma’s shift toward scalable cell therapies

OnTrak Wireless: Total Bearing Health Solution

Sponsored

OnTrak Wireless: Total Bearing Health Solution

OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified

Sponsored

OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified

Trending

Lonza confirms full-year 2025 outlook for CDMO business amid geopolitical uncertainty

Thermo Fisher CEO says Most Favored Nation and tariff policies are better than feared

Editor’s (re)View: Lonza and Thermo Fisher roll on despite volatility in business environment

Sponsored Picks

Sponsored

OnTrak Wireless: Total Bearing Health Solution

Sponsored

AI-Powered QMS: The Future of Quality Management

Sponsored

OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified